MARC record from Internet Archive

LEADER: 02174cam 2200529Ia 4500
001 ocm49828213
003 OCoLC
005 20180830215913.0
008 020520s2002 okua b 001 0 eng d
040 $aTSA$beng$cTSA$dOCLCQ$dBAKER$dYDXCP$dOCLCG$dUAB$dOCLCQ$dOCLCO$dOCLCQ$dNJR$dOCLCQ$dOCLCF$dCSA$dGZH$dOCLCO
020 $a1884735681
020 $a9781884735684
035 $a(OCoLC)49828213
050 4 $aRC685.C6$bB425 2002
060 4 $aQV 190 B396a 2002
082 04 $a616.1061
100 1 $aBecker, Richard C.
245 10 $aAntithrombotic therapy /$cRichard C. Becker, Dan J. Fintel, David Green.
250 $a2nd ed.
260 $aCaddo, Okla. :$bProfessional Communications,$c℗♭2002.
300 $axii, 352 pages :$billustrations ;$c19 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
504 $aIncludes bibliographical references and index.
650 0 $aThrombolytic therapy.
650 0 $aFibrinolytic agents$xTherapeutic use.
650 0 $aCardiovascular system$xDiseases$xChermotherapy.
650 0 $aAnticoagulants (Medicine)$xTherapeutic use.
650 7 $aAnticoagulants (Medicine)$xTherapeutic use.$2fast$0(OCoLC)fst00810470
650 7 $aFibrinolytic agents$xTherapeutic use.$2fast$0(OCoLC)fst00923667
650 7 $aThrombolytic therapy.$2fast$0(OCoLC)fst01150419
650 12 $aFibrinolytic Agents$xtherapeutic use.
650 12 $aCardiovascular Diseases$xdrug therapy.
650 22 $aThrombosis$xphysiology.
650 22 $aPlatelet Aggregation Inhibitors$xtherapeutic use.
650 22 $aThrombolytic Therapy.
650 22 $aMyocardial Infarction$xtherapy.
650 22 $aPulmonary Embolism$xdrug therapy.
700 1 $aFintel, Dan J.
700 1 $aGreen, David,$d1934-
776 08 $iOnline version:$aBecker, Richard C.$tAntithrombotic therapy.$b2nd ed.$dCaddo, Okla. : Professional Communications, ℗♭2002$w(OCoLC)777168302
938 $aBaker & Taylor$bBKTY$c24.95$d29.90$i1884735681$n0003991815$sactive
938 $aYBP Library Services$bYANK$n1868413
029 1 $aNZ1$b7237635
994 $aZ0$bP4A
948 $hNO HOLDINGS IN P4A - 28 OTHER HOLDINGS